Practical recommendations for the drug treatment of bacterial infections of the male genital tract including urethritis, epididymitis and prostatitis

Drugs

Volumn 57, Issue 5, 1999, Pages 743-750

  Joly Guillou, Marie Laure ^a   Lasry, Serge ^a  

^a HÔPITAL LOUIS MOURIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; ERYTHROMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

AGE; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CHLAMYDIA TRACHOMATIS; ENTEROBACTERIACEAE; EPIDIDYMITIS; GENITAL TRACT INFECTION; HAEMOPHILUS; HUMAN; MALE; MALE GENITAL SYSTEM; MYCOPLASMA; NEISSERIA GONORRHOEAE; PATIENT COMPLIANCE; PROSTATITIS; REVIEW; SEXUALLY TRANSMITTED DISEASE; URETHRITIS;

ANTI-BACTERIAL AGENTS; EPIDIDYMITIS; GENITAL DISEASES, MALE; HUMANS; MALE; PROSTATITIS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; URETHRITIS;

EID: 0032953733     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199957050-00007     Document Type: Review

References (31)

1. Meria P, Janier M, Desgrandchamps F, et al. Sexually transmitted disease in men. Prog Urol 1996; 6 (3): 447-54
2. Centers for Disease Control. 1998 Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 1997; RR1: 47
3. Centers for Disease Control. Chlamydia trachomatis genital infections in United States: 1995. MMWR Morb Mortal Wkly Rep 1997; 46 (9): 193-7
4. Janier M, Lassau F, Casin I, et al. Male urethritis with and without discharge: a clinical and microbiological study. Sex Transm Dis 1995; 22 (4): 244-52
5. Joly-Guillou ML, Judlin P, Lefévre JC, et al. Bactéries isolées en 1994-1995 au cours des infections gynécologiques hautes et des urethrites masculines: distribution et sensibilité aux antibiotiques. Presse Medicale 1996; 25 (8): 342-8
6. Jensen JS, Orsum R, Dohn B, et al. Mycoplasma genitalium: a cause of male urethritis? Genitourin Med 1993; 69 (4): 265-9
7. Uno M, Deguchi T, Komeda H, et al. Prevalence of Mycoplasma genitalium in men with gonococcal urethritis. Int J STD AIDS 1996; 7 (6): 443-4
8. Sharma S, Brousseau R, Kasatiya S. Detection and confirmation of Mycoplasma pneumoniae in urogenital specimens by PCR. J Clin Microbiol 1998; 36 (1): 277-80
9. Lefevre JC, Lepargneur JP, Bauriaud R, et al. Clinical and microbiologic features of urethritis in men in Toulouse, France. Sex Trans Dis 1991; 18 (2): 76-9
10. Vasquez F, Andres MT, Palacio V, et al. Isolation of Haemophilus influenzae and Haemophilus parainfluenzae in genitourinary infections: a 4 years review. Enferm Infecc Microbiol Clin 1996; 14 (3): 181-5
11. Bhuiyan B, Rahman M, Miah MRA, et al. Antimicrobial susceptibilities and plamid contents of Neisseria gonorrhoeae isolates from commercial sex workers in Dhaka, Bangladesh: emergence of high-level resistance to ciprofloxacin. J Clin Microbiol 1999; 37 (4): 1130-6
12. Van de Laar MJ, Van Duynhoven YT, Dessens M, et al. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the Netherlands 1977-1995. Genitourin Med 1997; 73: 510-7
13. Ngcow YF, Ramachandran S, Cheong YM. Treatment of gonorrhea with sulbactam/ampicillin. Sex Transm Dis 1991; 18 (3): 192-4
14. Jones RB, Van der Pol B, Jonhson RB. Susceptibility of Chlamydia trachomatis to trovafloxacin. J Antimicrob Chemother 1997; 39 (B Suppl.): 63-5
15. Moi H, Morel P, Gianotti B, et al. Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men. J Antimicrob Chemother 1996; 37 (A Suppl.): 115-22
16. Philips I, Dimian C, Barlow D, et al. A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men. J Antimicrob Chemother 1996; 37 (A Suppl.): 123-34
17. Ronald AR, Peeling RW. Chlamydial infections and quinolones. Eur J Clin Microbiol Infect Dis 1991; 10 (4): 351-4
18. Jones RB. New treatments for Chlamydia trachomtis. Am J Obstet Gynecol 1991; 164 (6): 1789-93
19. Bogaerts J, Tello WM, Akingeneye J, et al. Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoeae and decrease susceptibility to quinolones over time in Rwanda. Genitourin Med 1993; 69 (3): 196-200
20. Centers for Disease Control. Fluoroquinolones resistance in Neisseria gonorrhoeae: Colorado, Washington 1995. MMWR Morb Mortal Wkly Rep 1995; 44: 761-4
21. Gordon SM, Carlyn CJ, Doyle LJ, et al. The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: epidemiology and risk factors. Ann Intern Med 1996; 125: 465-70
22. Deguchi T, Saito I, Tanaka M, et al. Fluoroquinolone treatment failure in gonorrhoea: emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinoles. Sex Transm Dis 1997; 24 (5): 247-50
23. Vila J, Olmos L, Ballesteros J, et al. Development of in-vivo resistance after quinolone treatment of gonococcal urethritis. J Antimicrob Chemother 1997; 39 (6): 841
24. Kenny GE, Hooton TM, Roberts MC, et al. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrob Agent Chemother 1989; 33 (1): 103-7
25. Nilsson S, Johannisson G, Lycke E. Treatment of complicated infections of the male genital tract, with emphasis on Chlamydia trachomatis. Scand J Infect Dis Suppl 1982; 32: 173-6
26. Carlin EM, Barlon SE. Azithromycin as the first-line treatment of non-gonococcal urethritis (NGU): a study of follow-up rates, contact attendance and patients treatment preference. Int J STD AIDS 1996; 7 (3): 185-9
27. Lauharanta J, Saarinen K, Mustonen MT, et al. Single-dose oral azithromycin versus seven day doxycycline in the treatment of non-gonococcal urethritis in males. J Antimicrob Chemother 1993; 31 (E Suppl.): 177-83
28. Lister PJ, Balechandran T, Ridgway GL, et al. Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men. J Antimicrob Chemother 1993; 31 (E Suppl.): 185-92
29. Thorpe EM, Stamin WE, Hook EW, et al. Chlamydial cervitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practices. Genitourin Med 1996; 72 (2): 93-7
30. Waugh MA. Azithromycin in sexually transmitted disease: an overview. Int J STD AIDS 1991; 49 (2): 246-7
31. Wendel TD. 1-day azithromycin was as effective as 7-day doxycyclinc for non gonococcal urethritis syndrome in men. ACP J Club 1996: 125 (3): 82